These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24508597)

  • 1. Differential effects of estrogen exposure on arylsulfatase B, galactose-6-sulfatase, and steroid sulfatase in rat prostate development.
    Feferman L; Bhattacharyya S; Birch L; Prins GS; Tobacman JK
    J Steroid Biochem Mol Biol; 2014 Sep; 143():105-14. PubMed ID: 24508597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct effects of N-acetylgalactosamine-4-sulfatase and galactose-6-sulfatase expression on chondroitin sulfates.
    Bhattacharyya S; Kotlo K; Shukla S; Danziger RS; Tobacman JK
    J Biol Chem; 2008 Apr; 283(15):9523-30. PubMed ID: 18285341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid sulfatase, arylsulfatases A and B, galactose-6-sulfatase, and iduronate sulfatase in mammary cells and effects of sulfated and non-sulfated estrogens on sulfatase activity.
    Bhattacharyya S; Tobacman JK
    J Steroid Biochem Mol Biol; 2007 Jan; 103(1):20-34. PubMed ID: 17064891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arylsulfatase B (N-acetylgalactosamine-4-sulfatase): potential role as a biomarker in prostate cancer.
    Feferman L; Bhattacharyya S; Deaton R; Gann P; Guzman G; Kajdacsy-Balla A; Tobacman JK
    Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):277-84. PubMed ID: 23835622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of salt exposure on N-acetylgalactosamine-4-sulfatase (arylsulfatase B) activity, glycosaminoglycans, kininogen, and bradykinin.
    Kotlo K; Bhattacharyya S; Yang B; Feferman L; Tejaskumar S; Linhardt R; Danziger R; Tobacman JK
    Glycoconj J; 2013 Oct; 30(7):667-76. PubMed ID: 23385884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arylsulfatase B modulates neurite outgrowth via astrocyte chondroitin-4-sulfate: dysregulation by ethanol.
    Zhang X; Bhattacharyya S; Kusumo H; Goodlett CR; Tobacman JK; Guizzetti M
    Glia; 2014 Feb; 62(2):259-71. PubMed ID: 24311516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decline in arylsulfatase B and Increase in chondroitin 4-sulfotransferase combine to increase chondroitin 4-sulfate in traumatic brain injury.
    Bhattacharyya S; Zhang X; Feferman L; Johnson D; Tortella FC; Guizzetti M; Tobacman JK
    J Neurochem; 2015 Aug; 134(4):728-39. PubMed ID: 25943740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to common food additive carrageenan leads to reduced sulfatase activity and increase in sulfated glycosaminoglycans in human epithelial cells.
    Yang B; Bhattacharyya S; Linhardt R; Tobacman J
    Biochimie; 2012 Jun; 94(6):1309-16. PubMed ID: 22410212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of CFTR modifiers on arylsulfatase B activity in cystic fibrosis and normal human bronchial epithelial cells.
    Bhattacharyya S; Feferman L; Tobacman JK
    Pulm Pharmacol Ther; 2016 Feb; 36():22-30. PubMed ID: 26656789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of chondroitin-4-sulfotransferase (CHST11) expression by opposing effects of arylsulfatase B on BMP4 and Wnt9A.
    Bhattacharyya S; Feferman L; Tobacman JK
    Biochim Biophys Acta; 2015 Mar; 1849(3):342-52. PubMed ID: 25511584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydrotestosterone inhibits arylsulfatase B and Dickkopf Wnt signaling pathway inhibitor (DKK)-3 leading to enhanced Wnt signaling in prostate epithelium in response to stromal Wnt3A.
    Bhattacharyya S; Feferman L; Tobacman JK
    Prostate; 2019 May; 79(7):689-700. PubMed ID: 30801800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decline in arylsulfatase B expression increases EGFR expression by inhibiting the protein-tyrosine phosphatase SHP2 and activating JNK in prostate cells.
    Bhattacharyya S; Feferman L; Han X; Ouyang Y; Zhang F; Linhardt RJ; Tobacman JK
    J Biol Chem; 2018 Jul; 293(28):11076-11087. PubMed ID: 29794138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arylsulfatase B regulates versican expression by galectin-3 and AP-1 mediated transcriptional effects.
    Bhattacharyya S; Feferman L; Tobacman JK
    Oncogene; 2014 Nov; 33(47):5467-76. PubMed ID: 24240681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia reduces arylsulfatase B activity and silencing arylsulfatase B replicates and mediates the effects of hypoxia.
    Bhattacharyya S; Tobacman JK
    PLoS One; 2012; 7(3):e33250. PubMed ID: 22428001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arylsulfatase B regulates interaction of chondroitin-4-sulfate and kininogen in renal epithelial cells.
    Bhattacharyya S; Kotlo K; Danziger R; Tobacman JK
    Biochim Biophys Acta; 2010 May; 1802(5):472-7. PubMed ID: 20152898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased CHST15 follows decline in arylsulfatase B (ARSB) and disinhibition of non-canonical WNT signaling: potential impact on epithelial and mesenchymal identity.
    Bhattacharyya S; Feferman L; Han X; Xia K; Zhang F; Linhardt RJ; Tobacman JK
    Oncotarget; 2020 Jun; 11(24):2327-2344. PubMed ID: 32595831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exogenous recombinant N-acetylgalactosamine-4-sulfatase (Arylsulfatase B; ARSB) inhibits progression of B16F10 cutaneous melanomas and modulates cell signaling.
    Bhattacharyya S; O-Sullivan I; Tu J; Chen Z; Tobacman JK
    Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166913. PubMed ID: 37813168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decline in arylsulfatase B leads to increased invasiveness of melanoma cells.
    Bhattacharyya S; Feferman L; Terai K; Dudek AZ; Tobacman JK
    Oncotarget; 2017 Jan; 8(3):4169-4180. PubMed ID: 27926479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular signature of kappa-carrageenan mimics chondroitin-4-sulfate and dermatan sulfate and enables interaction with arylsulfatase B.
    Bhattacharyya S; Tobacman JK
    J Nutr Biochem; 2012 Sep; 23(9):1058-63. PubMed ID: 22079206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of colonic Wnt9A through Sp1-mediated transcriptional effects involving arylsulfatase B, chondroitin 4-sulfate, and galectin-3.
    Bhattacharyya S; Feferman L; Tobacman JK
    J Biol Chem; 2014 Jun; 289(25):17564-75. PubMed ID: 24778176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.